Delivery Order SPE2DB20D2014-SPE2DB25FC11F

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a prescription medication, with a ceiling value of $5,933.50 and an ultimate completion date of May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product, with a ceiling value of $3,657.51 and a period of performance through May 20, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,351.98 firm fixed-price delivery order contract is for the supply of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a pharmaceutical product, with a ceiling value of $8,594.99. The contract is a firm fixed price Delivery Order with a period of performance extending through May 20, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.53, is for the supply of 4,568,060,823 units of the drug Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of valsartan-HCTZ 320-25 mg tablets in 90-count packages, with a ceiling value of $1,039.95 and a performance period extending to May 12, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,129.42, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,872.05, is for the delivery of 4563133488 - VALSARTAN-HCTZ 80-12.5 MG TAB 90S, a cardiovascular medication. The contract is a firm fixed-price, delivery order type and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a generic blood pressure medication, with a ceiling value of $7,617.65 and a performance period through May 19, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALSARTAN-HCTZ 320-12.5 MG tablets in 90-count packages, with a ceiling value of $29,970.35. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FC11F
    Delivery Order

This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568436585 - VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product, with a ceiling value of $56,898.10 and a completion date of June 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated for this award. The contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for various government agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 9/2/25, 9:48 AM